RxDoctor Payments Data

Mary Scanlon, DO

Family Medicine · Lake Worth, FLNPI 1245240548

Payments from drug & device makers

$1,539in general payments, 2019–2025

Across 86 payments — averaging $17.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$390
  • Supernus Pharmaceuticals, Inc.$237
  • Novo Nordisk$157
  • Merck$102
  • Astellas Pharma US Inc$76
  • AstraZeneca$65
  • plus $512 from 18 others

What the payments were for

  • Food & beverage$1,47896%
  • Education$614%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,539 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$98,067
Medicare patients
231
Services billed
1,210

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf12$65,569
EliquisApixaban67$64,936
XareltoRivaroxaban49$55,000
OzempicSemaglutide40$42,295
Trelegy ElliptaFluticasone/Umeclidin/Vilanter58$40,692
JardianceEmpagliflozin29$29,615
MounjaroTirzepatide27$28,278
JanuviaSitagliptin Phosphate16$22,058
TrulicityDulaglutide11$14,644
Breo ElliptaFluticasone/Vilanterol25$14,597
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen307$11,759
Methylphenidate ErMethylphenidate Hcl18$9,424
Emgality PenGalcanezumab-Gnlm12$8,027
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen276$5,711
Fluticasone-SalmeterolFluticasone Propion/Salmeterol32$5,079

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$42$64,93667 claims
GSKTrelegy Ellipta, Breo Ellipta$32$55,28883 claims
Johnson & JohnsonXarelto$26$55,00049 claims
Novo NordiskOzempic$157$42,29540 claims
MerckJanuvia$102$22,05816 claims
AstraZenecaSymbicort$65$4,40512 claims
AbbVieSynthroid$390$3,90133 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Lake Worth

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →